Asterias Biotherapeutics, Inc. (OTCBB: ASTY) announced today that on
October 1, 2014 the company will distribute 8,000,000 warrants to
purchase common shares of BioTime, Inc. (the “BioTime Warrants”) at a
purchase price of $5.00 per common share to holders of record on
September 15, 2014 of its Series A common stock.
Aston Hotels & Resorts, an operating business of Interval Leisure Group
(Nasdaq:IILG), announced that it has entered into property management
agreements with Split Rock Resort & Golf Club and The Mountain Laurel
Resort & Spa situated in the scenic Pocono Mountains region of Lake
AstraZeneca (NYSE: AZN) today announced that it has begun a pre-clinical
development program to evaluate the ability of investigational antibody,
MEDI2452, to rapidly and specifically reverse the antiplatelet effects
of ticagrelor in rare emergency situations such as urgent surgery, or in
the event of major bleeding.
By Alex MacDonald
LONDON--U.K.-listed pharmaceutical company AstraZeneca PLC on Tuesday said its pipeline of drugs is expected to drive strong and consistent revenue growth, delivering annual revenues in excess of $45 billion by 2023.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.